[1]Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 2007;341:1725-30.
[Pubmed] [2]McDonald SP, Russ GR. Survival of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand 1991-2001. Nephrol Dial Transplant 2002;17:2212-9.
[Pubmed] [3]Ojo AO, Wolfe RA, Agodoa LY, et al. Prognosis alter primary renal transplant failure and the beneficial effect of repeat transplantation. Transplantation 1998;66:16519.
[4]Rao PS, Schaubel DE, Wei G, Fenton SSA. Evaluating the survival benefit of kidney retransplantation. Transplantation 2006;82:669-74.
[Pubmed] [5]Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999;14:2332-42.
[Pubmed] [6]Excerpts from the United States renal data base. 2006 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. 7 Transplantation Am J Kidney Dis 2007;49(1):S147-58.
[7]Denny RR, Sumrani N, Miles AMV, et al. Survival on hemodialysis versus renal transplantation following primary renal allograft failure. Transplant Proc 1997;29:3602-4.
[Pubmed] [8]Gallichio MH, Hudson S, Young CJ, Diethelm AG, Deierhoi MH. Renal retransplantation at the University of Alabama at Birmingham: incidence and outcome. En: Cecka JM, Terasaki PI, eds. Los Angeles, CA: UCLA Tissue typing laboratory. Clinical transplants 1998;14:169-75.
[9]Howard RJ, Reed AI, van der Werf WJ, Hemming AW, Patton PR, Scornik JC. What happens to renal transplant recipients who lose their graft? Am J Kidney Dis 200138:31-5.
[10]10.Marcén R, Pascual J, Tato AM, et al. Renal transplant recipients outcome after losing the first graft. Transplant Proc 2003;35:1679-81.
[Pubmed] [11]Rigden S, Mehls O, Gellert R, on behalf of the scientific advisory board of the ERA-EDTA registry. Factors influencing second renal allograft survival. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999;14:566-9.
[12]Coupel S, Giral-Clase M, Karam G, et al. Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Intern 2003;64:674-80.
[13]13.Magee JC, Barr ML, Basadona GP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1424-33.
[14]Gill JS, Abichandani R, Khan S, Kausz AT, Pereira BJG. Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 2002;61:2193-200.
[Pubmed] [15]Arias M, Escallada R, Martín de Francisco MA, et al. Return to dialysis after renal transplantation. Which would be the best way? Kidney Int 2002;61(80):S85-8.
[16]Hirata M, Terasaki PI. Renal retransplantation. En: Cecka JM, Terasaki PI, eds. Los Angeles, CA: UCLA Tissue typing laboratory. Clinical Transplants 1994;34:419-33.
[17]Jordan SC, Pescovitz MD. Presensitization: the problem and its management. Clin J Am Soc Nephrol 2006;1:421-32.
[Pubmed] [18]Kriaa F, Laurian Y, Hiesse C, Tchernia G, Charpentier B. Five years¿ experience at one centre with protein A immunoadsorption in patients with deleterous allo/auttoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and postransplant patients relapsing with focal glomerular sclerosis. Nephrol Dial Transplant 1995;10(6):108-10.
[Pubmed] [19]19.Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch-positive recipients. Transplantation 2000;70:887-95.
[Pubmed] [20]Cho YW, Cecka JM. Crossmath test-An analysis of UNOS data from 1991-2000. En: Cecka JM, Terasaki PI, eds. Los Angeles, CA: UCLA Tissue typing laboratory. Clinical Transplants 2001;22:237-46.
[21]Bryan CF, Baier KA, Nelson PW, et al. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation 1998;66:1827-32.
[Pubmed] [22]Fernández-Juárez G, Pascual J, Marcén R, et al. Retrasplante renal en enfermos tratados con ciclosporina. Nefrología 1999;29:262-7.
[23]Sellers MT, Velidedeoglu E, Bloom ED, et al. Expanded ¿criteria donor kidneys: a single-center clinical and short-term financial analysis-cause for concern in retransplantation. Transplantation 2004;78:1670-5.
[Pubmed] [24]Almond PS, Matas AJ, Gillingham K, et al. Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 1991; 52:253-258.
[Pubmed] [25]Abouljoud MS, Deierhoi MH, Hudson SL, Diethelm AG. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995;60:138-44.
[Pubmed] [26]Gjertson DW. A multi-factor analysis of kidney regraft outcomes. En: Cecka JM, Terasaki PI, eds. Los Angeles, CA: UCLA Tissue typing laboratory. Clinical transplants 2002;28:335-49.
[27]Lair D, Coupel S, Giral M, et al. The effect of a first kidney transplant on a subsequent transplant outcome : an experimental and clinical study. Kidney Int 2005;67:2368-75.
[Pubmed] [28]Johnston O, Rose C, Landsberg D, Gourlay WA, Gill JS. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007;7:1961-7.
[Pubmed] [29]Khakhar AK, Shahinian VB, House AA, et al. The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome. Transplant Proc 2003;862-3.
[30]López-Gómez JM, Pérez-Floes I, Jofré R, et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erytropoietin resistance. J Am Soc Nephrol 2004;15:2494-501.
[Pubmed] [31]Christiaans MHL, Overhof R, ten Haafy A, Nieman F, van Hoof JP van den Berg-Loonen EM. No advantage of flow cytomatry crossmatch over complement-dependent cytotoxicity in immunologicaly well-documented renal allograft recipients. Transplantation 1996;62:1341-7.
[Pubmed] [32]Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal retransplants -a second class mistake. Transplantation 1994;57:515-9.
[Pubmed] [33]33.Miles CD, Schaubel DE, Jia X, Ojo AO, Port FK, Rao PS. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Ame J Transplant 2007;7:1140-7.
[34]Briganti EM, Epi MC, Russ GR, McNeil JJ, Tkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Eng J Med 2002;347:103-9.
[35]Pardon A, Audard V, Caillard, et al. Risk factors and outcome of focal and segmental glomerulonephritis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006;21:1053-9.
[Pubmed] [36]European best practice guidelines for renal transplantation (part 2). Late recurrence of primary glomerulonephritides. Nephrol Dial Transplant 2002;17:16-9.
[Pubmed] [37]Hickey D, Nalesnik M, Vivas C, et al. Renal retransplantation in patients who lost their allografts during management of previous post-transplant lymphoproliferative disease. Clin Transplant 1990;4:187-90.
[38]Demircin G, Rees L. Retransplantation after post-transplant lymphoproliferative disease. Pediatr Nephrol 1997;11:358-60.
[Pubmed] [39]Birkeland SA, Hamilton-Dutoit S, Bendtzen K. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorders: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance interleukin-18 course, and results of retransplantation. Transplantation 2003;76:153-8.
[Pubmed] [40]Karras A, Thervet E, Le Meur J, Baudet-Bonneville V, Kessler M, Legendre C. Successful, renal retransplantation after post-transplant lymphoproliferative disease. Am J Transplant 2004;4:1904-9.
[Pubmed] [41]Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Eng J Med 2002;347:488-96.
[42]Poduval RD, Meehan SM, Woodle ES, et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 2002;73:1166-9.
[Pubmed] [43]Ramos E, Vincenti F, Lu WX, et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004;77:131-3.
[Pubmed] [44]44.Womer KL, Meier-Kriesche H-U, Patton PR, et al. Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant 2006;6:209-13.
[Pubmed]